Translational Research
  • Featured content
    The first of 3 downloadable slidesets from a satellite symposium at the 2017 annual meeting in Chicago: Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, review critical data on the mechanisms of CDK4/6 inhibition and its clinical effects in various cancer types.
    Date Posted: 6/8/2017
  • Featured content
    In this downloadable slideset, Max S. Wicha, MD, reviews basic and clinical research relevant to the characterization and therapeutic implications of targeting cancer stem cells.
    Date Posted: 2/27/2015
  • Featured content
    Max S. Wicha, MD, reviews basic and clinical research relevant to the characterization and therapeutic implications of targeting cancer stem cells.
  • Featured content
    Ravi Salgia, MD, provides expert perspective on results of studies of MET-targeted agents being evaluated in a variety of tumor types.
  • Featured content
    Sagar Lonial, MD, and Robert Z. Orlowski, MD, PhD, review data from key multiple myeloma presentations from the 2012 clinical oncology meeting in Chicago, including results with new proteasome inhibitors, IMiDs, and monoclonal antibodies.
    Date Posted: 7/6/2012
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 1557 Shown
10 of 1557 Shown
Show 10 More
Loading...